Cases in high-tech sectors such as AI, semiconductors, advanced manufacturing, chemicals, and biotech Protection covers a wide range of assets, including algorithms, process know-how, database logic, equipment-embedded technology, and biological materials.
China’s anti-unfair competition enforcement system continues to evolve alongside the rapid growth of its digital and innovation economy. Between 2021 and 2024, judicial and administrative authorities handled tens of thousands of cases, reflecting both regulatory vigilance and market complexity. These pre-2025 cases reveal how local courts, regulatory agencies, and industry sectors jointly shape the enforcement landscape and how the 2025 revision of the Anti-Unfair Competition Law further extends these trends into the age of AI, algorithms, and data governance.
China's Supreme People's Court has released eight significant rulings that signal a new era of enforcement under the Anti-Unfair Competition Law (AUCL).
The question “What if my name is registered as a trademark without my consent?” arises frequently for renowned professionals whose names carry substantial commercial value. Recently, Jiaquan IP Law successfully defended a well-known Japanese silversmith against multiple bad-faith trademark applications in China, providing useful insights in how personal name rights can be invoked in trademark opposition and invalidation proceedings.
China’s intellectual property enforcement framework is no longer a patchwork of isolated measures. Over the past decade, it has developed into a comprehensive, multi-layered system combining customs controls, criminal penalties, administrative oversight, judicial guidance, and coordinated market supervision.
In China, patent infringement disputes often hinge on the stability of the underlying patent right. When patent validity is uncertain, courts face the critical task of balancing various interests, including primarily the patent holder's right to protect their innovation and the alleged infringer's right to avoid undue burden and seek remedies.
In 2009, Jiaquan IP Law supported a U.S. medical device company entering China’s national phase through the PCT system. In October 2024, the patent faced a complete invalidation challenge in China.
In recent years, breakthroughs in artificial intelligence (AI) technology have emerged continuously, making it a significant driving force behind a new wave of technological revolution and industrial transformation.
